An individual’s phenotype is not dictated solely by their genetic variants. Environmental factors – where we live, what we eat, exposures over time – interact with genes and can influence disease risk. See how small molecule biomarkers can be used to assess these environmental exposures and their influence on genes, to provide a more complete picture of disease risk and why disease develops.

Sapient reveals new layers of biological insight through rapid discovery of circulating biomarkers. If you’d like to learn how you can use our platform to advance your pipeline, set a time to talk here.

Platform Explainer: How Sapient Accelerates Biomarker Discovery

At Sapient, we believe biomarker-driven drug development can transform lives – and accelerate the process at a fraction of the time and cost. That’s why we’ve built a Discovery Engine to enable circulating biomarker discovery at unprecedented speed and scale. Watch to learn why we focus on small molecule… Read More